Summary
The publisher, the industry analysis specialist, has released its latest report, “United States of America (USA) - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in US. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.
The US pharmaceutical market is the largest by value in the world. It grew from $305B in 2011 at a Compound Annual Growth Rate (CAGR) of 2.7% to $377B in 2019. It is forecast to reach about $441B in 2025. The growth is due to the rising elderly population, increased access to healthcare services, high disease burden, and launch of innovative drugs. However, introduction of drug cost controls and increased focus on generic drugs pose barriers to the pharmaceutical industry. The economic impact of the COVID-19 pandemic is also expected to affect consumers’ purchasing power. The US medical devices market was estimated to be $142B in 2015, which increased at a CAGR of 4.8% to reach $170B in 2019. The market is expected to grow at a CAGR of 4.8% from $179B in 2020 to reach $226B in 2025.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in US, and includes -
Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
The publisher, the industry analysis specialist, has released its latest report, “United States of America (USA) - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in US. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.
The US pharmaceutical market is the largest by value in the world. It grew from $305B in 2011 at a Compound Annual Growth Rate (CAGR) of 2.7% to $377B in 2019. It is forecast to reach about $441B in 2025. The growth is due to the rising elderly population, increased access to healthcare services, high disease burden, and launch of innovative drugs. However, introduction of drug cost controls and increased focus on generic drugs pose barriers to the pharmaceutical industry. The economic impact of the COVID-19 pandemic is also expected to affect consumers’ purchasing power. The US medical devices market was estimated to be $142B in 2015, which increased at a CAGR of 4.8% to reach $170B in 2019. The market is expected to grow at a CAGR of 4.8% from $179B in 2020 to reach $226B in 2025.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in US, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Abbvie, Amgen, Gilead, Johnson & Johnson, and Pfizer.
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Alcon, GE Healthcare, Fresenius, and Roche Diagnostics
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the US healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving US healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact US healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
1. Table of Contents
2. Executive Summary
3. Overview of Pharmaceutical Market
4. Overview of Medical Devices Market
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
6. Deal Analysis
7. HealthTech Landscape
8. Market Access
9. Country Healthcare Landscape
10 Trade Associations, US
List of Tables
List of Figures
